Belgian Biotech Starts Phase Ib with an off-the-shelf mRNA Therapy for Melanoma
eTheRNA has started a Phase Ib trial in patients with melanoma to test a cancer immunotherapy…
eTheRNA has started a Phase Ib trial in patients with melanoma to test a cancer immunotherapy…
BioNTech has reported a new technology that could overcome some of the most challenging issues…
The young field of mRNA therapeutics is booming and generating huge expectations. Which are the main players…
Shire has sold its RNA therapy program to a smaller biotech that wants to accelerate…
New year, new list: here are the 10 hottest Biotech companies I will watch closely…
Curious about which technologies have attracted the most cash in biotech finance this year? Here's a…
From the hottest research areas to the most popular city for biotech, which biotech articles have…
CureVac has raised an additional €27M ($29.5M) that will help the company keep on its…
BioNTech has turned up the heat in the race to bring an mRNA immunotherapy for…
Moderna is taking Biotech investing to new heights, as it has now increased total fundraising&partnership…
The collaboration between AstraZeneca and the money-magnet Moderna is giving its first steps. AstraZeneca is…
Update (05/07/2017): BioNTech has published new results in Nature revealing a strong immune response in all…